Lee, P., Chandel, N. S. & Simon, M. C. Cellular adaptation to hypoxia through hypoxia inducible factors and beyond. Nat. Rev. Mol. Cell Biol. 21, 268–283 (2020).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Semenza, G. L. Hypoxia-inducible factor 1 and cardiovascular disease. Annu. Rev. Physiol. 76, 39–56 (2014).

Article  CAS  PubMed  Google Scholar 

Sousa Fialho, M. D. L., Abd Jamil, A. H., Stannard, G. A. & Heather, L. C. Hypoxia-inducible factor 1 signalling, metabolism and iats therapeutic potential in cardiovascular disease. Biochim. Biophys. Acta Mol. Basis Dis. 1865, 831–843 (2019).

Article  CAS  PubMed  Google Scholar 

Guimaraes-Camboa, N. et al. HIF1α Represses cell stress pathways to allow proliferation of hypoxic fetal cardiomyocytes. Dev. Cell 33, 507–521 (2015).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Menendez-Montes, I. et al. Myocardial VHL-HIF signaling controls an embryonic metabolic switch essential for cardiac maturation. Dev. Cell 39, 724–739 (2016).

Article  CAS  PubMed  Google Scholar 

Hu, Y., Lu, H., Li, H. & Ge, J. Molecular basis and clinical implications of HIFs in cardiovascular diseases. Trends Mol. Med. 28, 916–938 (2022).

Article  CAS  PubMed  Google Scholar 

Loboda, A., Jozkowicz, A. & Dulak, J. HIF-1 versus HIF-2-is one more important than the other? Vascul. Pharmacol. 56, 245–251 (2012).

Article  CAS  PubMed  Google Scholar 

Jaakkola, P. et al. Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation. Science 292, 468–472 (2001).

Article  CAS  PubMed  Google Scholar 

Ivan, M. et al. HIFalpha targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing. Science 292, 464–468 (2001).

Article  CAS  PubMed  Google Scholar 

Knutson, A. K., Williams, A. L., Boisvert, W. A. & Shohet, R. V. HIF in the heart: development, metabolism, ischemia, and atherosclerosis. J. Clin. Investig. 131, e137557 (2021).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Choudhry, H. & Harris, A. L. Advances in hypoxia-inducible factor biology. Cell Metab. 27, 281–298 (2018).

Article  CAS  PubMed  Google Scholar 

Downes, N. L., Laham-Karam, N., Kaikkonen, M. U. & Yla-Herttuala, S. Differential but complementary HIF1α and HIF2α transcriptional regulation. Mol. Ther. 26, 1735–1745 (2018).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wiesener, M. S. et al. Widespread hypoxia-inducible expression of HIF-2alpha in distinct cell populations of different organs. FASEB J. 17, 271–273 (2003).

Article  CAS  PubMed  Google Scholar 

Ramakrishnan, S. K. et al. Loss of von Hippel-Lindau protein (VHL) increases systemic cholesterol levels through targeting hypoxia-inducible factor 2α and regulation of bile acid homeostasis. Mol. Cell Biol. 34, 1208–1220 (2014).

Article  PubMed  PubMed Central  Google Scholar 

Fukushima, K., Kitamura, S., Tsuji, K. & Wada, J. Sodium-glucose cotransporter 2 inhibitors work as a "regulator" of autophagic activity in overnutrition diseases. Front. Pharmacol. 12, 761842 (2021).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Vaduganathan, M. et al. The global burden of cardiovascular diseases and risk: a compass for future health. J. Am Coll. Cardiol. 80, 2361–2371 (2022).

Article  PubMed  Google Scholar 

Zhou, X., Yu, L., Zhao, Y. & Ge, J. Panvascular medicine: an emerging discipline focusing on atherosclerotic diseases. Eur. Heart J. 43, 4528–4531 (2022).

Article  CAS  PubMed  Google Scholar 

Hu, Y. et al. Unwavering excellence: how to be a competent cardiovascular doctor in “panvascular medicine+”. Innovation 4, 100489 (2023).

PubMed  PubMed Central  Google Scholar 

Szewczak, L. Timeline: cellular oxygen sensing. Cell 167, 286 (2016).

Article  PubMed  Google Scholar 

Beckman, D. L., Lin, L. L., Quinones, M. E. & Longmore, G. D. Activation of the erythropoietin receptor is not required for internalization of bound erythropoietin. Blood 94, 2667–2675 (1999).

Article  CAS  PubMed  Google Scholar 

Bunn, H. F. et al. Erythropoietin: a model system for studying oxygen-dependent gene regulation. J. Exp. Biol. 201, 1197–1201 (1998).

Article  CAS  PubMed  Google Scholar 

Semenza, G. L., Nejfelt, M. K., Chi, S. M. & Antonarakis, S. E. Hypoxia-inducible nuclear factors bind to an enhancer element located 3' to the human erythropoietin gene. Proc. Natl Acad. Sci. USA 88, 5680–5684 (1991).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Semenza, G. L. & Wang, G. L. A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation. Mol. Cell Biol. 12, 5447–5454 (1992).

CAS  PubMed  PubMed Central  Google Scholar 

Wang, G. L. & Semenza, G. L. General involvement of hypoxia-inducible factor 1 in transcriptional response to hypoxia. Proc. Natl Acad. Sci. USA 90, 4304–4308 (1993).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang, G. L. & Semenza, G. L. Characterization of hypoxia-inducible factor 1 and regulation of DNA binding activity by hypoxia. J. Biol. Chem. 268, 21513–21518 (1993).

Article  CAS  PubMed  Google Scholar 

Firth, J. D., Ebert, B. L., Pugh, C. W. & Ratcliffe, P. J. Oxygen-regulated control elements in the phosphoglycerate kinase 1 and lactate dehydrogenase A genes: similarities with the erythropoietin 3' enhancer. Proc. Natl Acad Sci. USA 91, 6496–6500 (1994).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hu, Y. et al. Hypoxia and panvascular diseases: exploring the role of hypoxia-inducible factors in vascular smooth muscle cells under panvascular pathologies. Sci. Bull. 68, 1954–1974 (2023).

Article  Google Scholar 

Wang, G. L. & Semenza, G. L. Purification and characterization of hypoxia-inducible factor 1. J. Biol. Chem. 270, 1230–1237 (1995).

Article  CAS  PubMed  Google Scholar 

Wang, G. L., Jiang, B. H., Rue, E. A. & Semenza, G. L. Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. Proc. Natl Acad. Sci. USA 92, 5510–5514 (1995).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Forsythe, J. A. et al. Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol. Cell Biol. 16, 4604–4613 (1996).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Iyer, N. V. et al. Cellular and developmental control of O2 homeostasis by hypoxia-inducible factor 1 alpha. Genes Dev. 12, 149–162 (1998).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kibel, A., Iliopoulos, O., DeCaprio, J. A. & Kaelin, W. G. Jr. Binding of the von Hippel-Lindau tumor suppressor protein to Elongin B and C. Science 269, 1444–1446 (1995).

Article  CAS  PubMed  Google Scholar 

Iliopoulos, O. et al. Negative regulation of hypoxia-inducible genes by the von Hippel-Lindau protein. Proc. Natl Acad. Sci. USA 93, 10595–10599 (1996).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Maxwell, P. H. et al. The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature 399, 271–275 (1999).

Article  CAS  PubMed  Google Scholar 

Epstein, A. C. et al. C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation. Cell 107, 43–54 (2001).

Article  CAS  PubMed  Google Scholar 

Bruick, R. K. & McKnight, S. L. A conserved family of prolyl-4-hydroxylases that modify HIF. Science 294, 1337–1340 (2001).

Article  CAS  PubMed  Google Scholar 

Ivan, M. et al. Biochemical purification and pharmacological inhibition of a mammalian prolyl hydroxylase acting on hypoxia-inducible factor. Proc. Natl Acad. Sci. USA 99, 13459–13464 (2